Promakhos Therapeutics
A therapeutics platform for curing inflammatory disorders
Boston , US
Therapeutics
We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.
- Projects
- Team
- Jobs
- News
No projects yet.
This company hasn't published any projects. Be the first to launch one!
Create Your First ProjectFounded2021
Team Size2
LocationUS
Websitewww.promakhos.com/
🏳️
Claim This ListingIs this your company?
Claim this listing to manage your profile, add updates, and connect with your audience.